1. Dose selection for the investigational anticancer agent alisertib (MLN8237): Pharmacokinetics, pharmacodynamics, and exposure–safety relationships. (18th November 2014) Authors: Venkatakrishnan, Karthik; Zhou, Xiaofei; Ecsedy, Jeffrey; Mould, Diane R.; Liu, Hua; Danaee, Hadi; Fingert, Howard; Kleinfield, Robert; Milton, Ashley Journal: Journal of clinical pharmacology Issue: Volume 55:Number 3(2015:Mar.) Page Start: 336 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗